Search Results 1091-1100 of 19304 for Hemoglobin

1. Capecitabine and Bevacizumab With or Without Atezolizumab in Treating Patients With Refractory Metastatic Colorectal Cancer - Mayo Clinic

   Hemoglobin >= 9 g/dL continuation of erythropoietin products is permitted; hemoglobin ... hemoglobin level; Calculated creatinine clearance must be >= 50 ml ...

2. Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments - Mayo Clinic

   Hemoglobin > 9 g/dL;; Creatinine concentration ≤ 1.4 mg/dL, or creatinine clearance > 40 mL/min;; Total bilirubin < 1.5 mg/dL, ALT+ AST levels ≤ 3 times ...

3. A Study of Pembrolizumab (MK-3475) Versus Placebo in Combination with Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer - Mayo Clinic

   Hemoglobin* ≥ 9 g/dL or ≥ 5.6 mmol/L. Renal. Creatinine ≤ 1.5 × ULN; OR; Measured or calculated** creatinine clearance (GFR can also be used instead of ...

4. Eribulin Mesylate in Treating Patients With Recurrent or Refractory Osteosarcoma - Mayo Clinic

   Hemoglobin >= 8.0 g/dL (may receive red blood cell [RBC] transfusions); Creatinine clearance or radioisotope glomerular filtration rate (GFR) >= 70 mL/min ...

5. Adipose-Derived Mesenchymal Stem Cells (AMSCs) For Recurrent Glioblastoma - Mayo Clinic

   Hemoglobin ≥ 9 g/dL;; Platelets ≥ 100 x 10^9/L;; Absolute Neutrophil Count (ANC) ≥ 1.5 x 10^9/L. Willing to return to enrolling institution for follow-up ...

6. Myelofibrosis - Diagnosis and treatment - Mayo Clinic

   Find out more about this bone marrow cancer. Learn about symptoms, diagnosis and treatments for primary myelofibrosis and secondary myelofibrosis.

7. A Study of 9-ING-41 in Patients with Advanced Cancers - Mayo Clinic

   hemoglobin ≥ 8.5 g/dL, platelets ≥ 50,000/mL 2. Adequate liver function: transaminases (aspartate aminotransferase/ alanine aminotransferase, AST/ALT) and ...

8. The Use of the Cerebral Oximetry for Patients Undergoing Dynamic Computed Tomography Myelography under General Anesthesia - Mayo Clinic

   Systemic hemodynamic data (ie, heart rate, systemic blood pressure, peripheral hemoglobin oxygen saturation); Cerebral oximetric data recorded at 2 minute ...

9. Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors - Mayo Clinic

   Hemoglobin ≥8.0 g/dL. Total bilirubin ≤1.5× upper limit of normal (ULN) or ≤× ULN for subjects with Gilbert's disease. Alanine aminotransferase (ALT) and ...

10. A Study of the Effect of Dalcetrapib on Cardiovascular Risk for a Genetically Defined Population who have had a Recent Acute Coronary Syndrome Event - Mayo Clinic

    Last known hemoglobin <10 g/dL; Index ACS event presumed due to uncontrolled hypertension. Participating Mayo Clinic locations. Study statuses change often ...